Identifying Short Half-Life Compounds from Structure Information Using Multi-Task Graph Neural Networks
Accurate prediction of terminal half-life (t1/2) is paramount for prioritizing drug candidates during the lead optimization stage, as it minimizes the risk of clinical trial failure while optimizing resource allocation. Drugs characterized by suboptimal t1/2 profileseither excessively short or prolongedpresent sign...